GLIS2 and metabolic dysfunction-associated steatohepatitis: The study further indicates that GLIS2 plays a critical role in promoting NASH-associated reprogramming in hepatic fibrosis, inflammation, and apoptosis; however, hepatic steatosis remained unaffected.